Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. ETX.L Share Price
  4. ETX.L Share Regulatory News
  5. Director/PDMR Shareholding

Pin to quick picksETX.L Regulatory News (ETX)

ETX.L Information
  • There is currently no data for ETX

Director/PDMR Shareholding

4 Mar 2013 15:23

RNS Number : 1779Z
e-Therapeutics plc
04 March 2013
 

 

4 March 2013

 

Holdings in Company: e-Therapeutics plc

 

e-Therapeutics plc (AIM: ETX) was notified on 1 March that following the completion of the share placings announced that day the resultant holdings of the Company's CEO Professor Malcolm Young were as shown below:

 

Number of ordinary shares

% of issued share capital

Direct beneficial interest

20,644,958

7.84

Indirect interest*

377,784

0.14

Total beneficial interest

21,022,742

7.99

 

* Held through Professor Young's interest in Novotech Investment Limited and Novotech Syndicate LLP

 

-Ends-

 

Contacts:

 

e-Therapeutics plc

Daniel Elger

Tel: +44 (0) 7909 915 068

www.etherapeutics.co.uk 

 

Panmure Gordon (UK) Limited

Corporate Finance: Fred Walsh / Grishma Patel

Corporate Broking: Hannah Woodley

Tel: +44 (0) 20 7886 2500

www.panmure.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFLEVAISIIV
12345678910
Date   Source Headline
9th May 20247:00 amRNSCancellation - e-Therapeutics Plc
8th May 20247:00 amRNSLast Day of Dealings on AIM
3rd May 20246:00 pmRNSe-therapeutics
29th Apr 20242:09 pmRNSResult of General Meeting
10th Apr 20247:00 amRNSProposed Fundraise of £28.9m and Cancellation
31st Jan 20244:30 pmRNSTotal Voting Rights
24th Jan 202410:04 amRNSExercise of Options and Issue of Equity
16th Jan 20247:00 amRNSBusiness Update
9th Jan 20244:04 pmRNSDirector Dealing and Issue of Equity
27th Dec 20237:00 amRNSUpdate on OTCQX Market Listing
13th Nov 20239:05 amEQSEdison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery
2nd Nov 20237:00 amRNSStrategic RWE collaboration with Arcturis
26th Oct 20237:38 amRNSInterim results for the six months to 31 July 2023
19th Oct 20239:54 amRNSNotice of Interim Results
20th Sep 20237:00 amRNSSenior Management Update
7th Sep 202311:47 amRNSExercise of Options and Issue of Equity
31st Jul 20234:30 pmRNSTotal Voting Rights
18th Jul 20234:20 pmRNSResult of Annual General Meeting
6th Jul 20235:27 pmRNSDirector Dealing and Issue of Equity
30th Jun 20237:00 amRNSInvestor Presentation
26th Jun 20237:00 amRNSNotice of Investor Presentation
11th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
4th May 20237:00 amRNSFinal results for the year ended 31 January 2023
28th Apr 20234:30 pmRNSTotal Voting Rights
27th Apr 20237:00 amRNSNotification of Full Year Results Date
28th Mar 20233:57 pmRNSExercise of Options and Issue of Equity
21st Feb 20234:35 pmRNSPrice Monitoring Extension
20th Feb 202310:19 amRNSDirector/PDMR Shareholding
7th Feb 20237:00 amRNSFiling of four patent applications
31st Jan 20237:00 amRNSTotal Voting Rights
4th Jan 20233:15 pmRNSDirector Dealing and Issue of Equity
29th Dec 20224:40 pmRNSSecond Price Monitoring Extn
29th Dec 20224:35 pmRNSPrice Monitoring Extension
20th Dec 20224:35 pmRNSPrice Monitoring Extension
31st Oct 20227:00 amRNSTotal Voting Rights
12th Oct 20223:12 pmRNSHolding(s) in Company
11th Oct 202210:42 amRNSHolding(s) in Company
10th Oct 20228:03 amRNSHolding(s) in Company
30th Sep 20227:00 amRNSInterim results for the six months to 31 July 2022
30th Sep 20227:00 amRNSFundraise of £13.5 million by way of Subscription
26th Sep 20224:40 pmRNSSecond Price Monitoring Extn
26th Sep 20224:36 pmRNSPrice Monitoring Extension
1st Aug 20227:00 amRNSFiling of eight patent applications
29th Jul 20227:00 amRNSTotal Voting Rights
20th Jul 202210:39 amRNSResult of Annual General Meeting
6th Jul 20227:00 amRNSNotice to Shareholders - AGM Virtual Access
5th Jul 20227:00 amRNSDirector Dealing and Issue of Equity
17th May 20227:00 amRNSNotice of AGM and Posting of Annual Report
4th May 20227:00 amRNSFinal results for the year ended 31 January 2022
27th Apr 20227:00 amRNSNotification of Full Year Results Date
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
BGS
Baillie Gifford Shin Nippon PLC
LSE
-1.67%
GWI
Globalworth
LSE
-0.59%
UAV
Unicorn Asset Management
LSE
0.00%
BOOM
Audioboom Grp.
LSE
-1.75%
THRG
Throgmorton Trust
LSE
0.00%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
5.56%
MPL
Mercantile Ports & Logistics
LSE
-13.79%
ITM
Itm Power
LSE
-7.38%
PPP
Pennpetro Energy
LSE
0.00%
ECR
ECR Minerals
LSE
-12.50%